DK500083A - Fremgangsmaade til fremstilling af 5-(2-alkoxyphenyl)hydantoin-forbindelser eller farmaceutisk acceptable salte deraf - Google Patents

Fremgangsmaade til fremstilling af 5-(2-alkoxyphenyl)hydantoin-forbindelser eller farmaceutisk acceptable salte deraf Download PDF

Info

Publication number
DK500083A
DK500083A DK500083A DK500083A DK500083A DK 500083 A DK500083 A DK 500083A DK 500083 A DK500083 A DK 500083A DK 500083 A DK500083 A DK 500083A DK 500083 A DK500083 A DK 500083A
Authority
DK
Denmark
Prior art keywords
alcoxyphenyl
preparation
acceptable salts
pharmaceutical acceptable
hydantoin compounds
Prior art date
Application number
DK500083A
Other languages
English (en)
Other versions
DK500083D0 (da
DK157996C (da
DK157996B (da
Inventor
Rodney C Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK500083D0 publication Critical patent/DK500083D0/da
Publication of DK500083A publication Critical patent/DK500083A/da
Publication of DK157996B publication Critical patent/DK157996B/da
Application granted granted Critical
Publication of DK157996C publication Critical patent/DK157996C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK500083A 1982-11-01 1983-11-01 Analogifremgangsmaade til fremstilling af 5-(2-alkoxyphenyl)-hydantoinderivater eller farmaceutisk acceptable salte deraf DK157996C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43820082 1982-11-01
US06/438,200 US4457939A (en) 1982-11-01 1982-11-01 Aldose reductase inhibiting 5-(2-alkoxy-3-substituted phenyl)hydantoins

Publications (4)

Publication Number Publication Date
DK500083D0 DK500083D0 (da) 1983-11-01
DK500083A true DK500083A (da) 1984-05-02
DK157996B DK157996B (da) 1990-03-12
DK157996C DK157996C (da) 1990-08-06

Family

ID=23739665

Family Applications (1)

Application Number Title Priority Date Filing Date
DK500083A DK157996C (da) 1982-11-01 1983-11-01 Analogifremgangsmaade til fremstilling af 5-(2-alkoxyphenyl)-hydantoinderivater eller farmaceutisk acceptable salte deraf

Country Status (13)

Country Link
US (1) US4457939A (da)
KR (1) KR860001508B1 (da)
CA (1) CA1195689A (da)
DK (1) DK157996C (da)
ES (1) ES526842A0 (da)
FI (1) FI80682C (da)
GR (1) GR79639B (da)
HU (1) HU193187B (da)
MX (1) MX164727B (da)
PH (1) PH18396A (da)
PL (1) PL140522B1 (da)
PT (1) PT77579A (da)
YU (1) YU43837B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS227569B1 (en) * 1982-09-24 1984-04-16 Oldrich Kreuz Spring-loading of motorcycle rear wheel
US4609663A (en) * 1984-09-11 1986-09-02 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in glaucoma therapy
US7122700B2 (en) * 2004-07-30 2006-10-17 Xerox Corporation Arylamine processes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5492961A (en) * 1977-12-29 1979-07-23 Ajinomoto Co Inc Production of 5-arylhydantoin
FR2458546A1 (fr) * 1979-06-07 1981-01-02 Hoechst France Procede de fabrication d'aryl-5 hydantoines racemiques et produits nouveaux en resultant

Also Published As

Publication number Publication date
KR860001508B1 (ko) 1986-09-30
KR840006631A (ko) 1984-12-01
FI833994A (fi) 1984-05-02
PH18396A (en) 1985-06-21
YU43837B (en) 1989-12-31
FI833994A0 (fi) 1983-10-31
CA1195689A (en) 1985-10-22
YU216883A (en) 1986-02-28
MX164727B (es) 1992-09-21
HU193187B (en) 1987-08-28
GR79639B (da) 1984-10-31
DK500083D0 (da) 1983-11-01
ES8504144A1 (es) 1985-04-16
PL140522B1 (en) 1987-05-30
PL244351A1 (en) 1984-09-24
PT77579A (en) 1983-11-01
DK157996C (da) 1990-08-06
DK157996B (da) 1990-03-12
ES526842A0 (es) 1985-04-16
US4457939A (en) 1984-07-03
FI80682C (fi) 1990-07-10
FI80682B (fi) 1990-03-30

Similar Documents

Publication Publication Date Title
DK160940C (da) Analogifremgangsmaade til fremstilling af benzoheterocycliske forbindelser eller farmaceutisk acceptable salte deraf
DK163359C (da) Analogifremgangsmaade til fremstilling af n-imidazolylderivater af bicycliske forbindelser eller pharmaceutisk acceptable salte deraf
DK28282A (da) Fremgangsmaade til fremstilling af hexapyranoseforbindelser eller salte deraf
DK552581A (da) Fremgangsmaade til fremstilling af 3-pyridylaklyl-indol-forbindelser eller farmaceutisk acceptable salte deraf
DK148537C (da) Analogifremgangsmaade til fremstilling af 3-aminopyridazinforbindelser eller farmaceutisk acceptable salte deraf
DK161968C (da) Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf
DK70083D0 (da) Fremgangsmade til fremstilling af pyrroleddikesyreamider eller salte deraf
DK162842C (da) Analogifremgangsmaade til fremstilling af 1-perfluoralkyl-2-(1,2,4-triazol-1-yl)-ethanol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK158306C (da) Analogifremgangsmaade til fremstilling af substituerede pyridylallylforbindelser eller farmaceutisk acceptable salte deraf
DK335279A (da) Fremgangsmaade til fremstilling af spirofuranohydantoin-forbindelser eller farmaceutisk acceptable metalsalte deraf
DK161699C (da) Analogifremgangsmaade til fremstilling af 4-aryl-4-piperidincarbinoler eller farmaceutisk acceptable salte deraf
DK321482A (da) Fremgangsmaade til fremstilling af 1-imidazolyl-2-phenyl-8-piperazinylphenoxy-octan-2-ol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK448783A (da) Fremgangsmaade til fremstilling af n-substituerede 2-(1-imidazolyl)-indoler eller farmaceutisk acceptable salte deraf
DK157135C (da) Analogifremgangsmaade til fremstilling af 1,2,4-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK275383D0 (da) Fremgangsmade til fremstilling af 1-(2-heterocyclyl-2-(5-chlor-2-pyridyl)-2-hydroxy-ethyl)-1,2,4-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK115379A (da) Fremgangsmaade til fremstilling af dilignoler eller dilignollignende forbindelser eller salte heraf
DK500083A (da) Fremgangsmaade til fremstilling af 5-(2-alkoxyphenyl)hydantoin-forbindelser eller farmaceutisk acceptable salte deraf
DK149823C (da) Fremgangsmaade til fremstilling af kijanimicin eller farmaceutisk acceptable salte heraf
DK210183A (da) Fremgangsmaade til fremstilling af piperidinoquinazolin-forbindelser eller farmaceutisk acceptable salte deraf
DK224381A (da) Fremgangsmaade til fremstilling af benzazolderivater eller salte deraf
DK432582A (da) Fremgangsmaade til fremstilling af aminooxazolylforbindelser eller salte deraf
DK226883A (da) Fremgangsmaade til fremstilling af trialkylsiliciumholdige phenylcycloalkan-forbindelser eller farmaceutisk acceptable salte deraf
DK499983D0 (da) Fremgangsmade til fremstilling af 5-phenyl-hydantoin-forbindelser eller farmaceutisk acceptable salte deraf
DK149479A (da) Fremgangsmaade til fremstilling af betalactamforbindelser eller farmaceutisk acceptable salte deraf
DK186283D0 (da) Fremgangsmade til fremstilling af imidazoquinoxaliner eller salte deraf

Legal Events

Date Code Title Description
PBP Patent lapsed